BNET Industries

Market Cap:$150.4B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Barclays appoints US lev loan syndicate head - memo
-
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Roche's Merger Formula for Genentech
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
-
FDA panel backs Pfizer's anti-infection vaccine for kids
-
Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started
-
Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China
-
EDITORIAL: Difficult mix of business, science
-
$75M verdict unsealed in Prempro-cancer case
-
Sanofi-Aventis on hunt for Boston partners
News & Analysis
Filter by
jim edwards and pfizer inc. - All News and Analysis
Pfizer Blasted in Canada for $780K CME Program
Pfizer PFE can't catch a break in Canada right now. It's being blasted for a C$780,000 continuing medical education program it has set up through the Canadian Medical Association. Critics believe that doctor education should not be influenced by drug companies, which have a different set of interests than patients....
"Creepy" Pfizer Worker Charged With Murder
Eric Lau, the Pfizer PFE worker wanted in connection with the beating and stabbing death of a neighbor, was arrested Wednesday and charged with murder. Lau, 32, a contract worker at Pfizer's Pearl River, N.Y., plant, was arrested after a sniffer-dog manhunt in a wooded area near New City, N.Y....
Cops Hunt Alleged Killer at Pfizer; Didn't Show Up for Work After Neighbor Found Stabbed
Police have launched a manhunt for a Pfizer PFE worker in connection with the fatal stabbing of a 32-year-old teacher. Eric Lau's 2007 Toyota Scion was found shortly after 8 a.m. this morning in New City, N.Y., according to LoHud.com. Lau at right did not show up to work yesterday...
UPDATED: Suicide Follows Stabbing Linked to Pfizer Layoffs
The body of a man was found in the parking lot of Pfizer PFE’s Pearl River, N.Y., site in a possible suicide, police say. Pfizer plans about 200 layoffs at the site. It is the second violent incident associated with layoffs at the company. A few days ago, a former...
J&J CEO Rubs Pfizer's Face in Disastrous Consumer Products Sale of '06
Toldya: One year ago, BNET noted that Pfizer PFE must have been crazy to sell its consumer products unit to Johnson & Johnson JNJ. The deal included brands such as Nicorette, Zantac and Benadryl. J&J's Q3 earnings report showed that the consumer products unit has done much better than its...
Pfizer Got $160M in Tax Money to Build in Connecticut
Want Pfizer PFE to build a new plant in your town? That could be an expensive date, according to a McClatchy-Tribune News service report. It cost Connecticut taxpayers $160 million to host the world's largest drug company between 2000 and 2011: by Jim Edwards
Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash
Merck MRK has produced a set of numbers giving a look at the scale of the combined company with Schering-Plough. One surprise: The new company is still just a little bit smaller than the old Pfizer PFE was. The new Merck would have had annual sales $46.7 billion, compared to...
Why Pfizer Wants Your Car-Sick Dog to Travel on Thanksgiving
Thanksgiving plus recession equals car sickness drugs for dogs, according to a new press release from Pfizer PFE. The company is urging people to bring their dogs with them as they travel for Thanksgiving dinner. Why? Because Pfizer makes a motion-sickness drug for dogs, Cerenia, so now there's no excuse...
Pfizer Scientist Stabbed Wife After Job Loss, Police Say
A former Pfizer PFE employee who lost his job and “was convinced he could not provide for his family any further,†has been charged with stabbing his wife, according to police. Pfizer is in the process of laying off 19,500 employees in its merger with Wyeth. Asbill was involved in...
As Tax Breaks for Pfizer End, Jobs Disappear
As Pfizer PFE reorganizes after its merger with Wyeth, municipalities are finding that the tax deals they once struck to keep the drug giant in town are having short-term advantages at best and, at worst, no effect at all. Pfizer must make 19,500 layoffs across its empire to make the...
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
